Scottish Health Survey 2014 - volume 1: main report
Presents results for the Scottish Health Survey 2014, providing information on the health and factors relating to health of people living in Scotland.
This document is part of a collection
Table 3.7 Products to support quit attempts, 2014, by age and sex
Smokers who have attempted to quit and recent ex-smokers (<1 year) aged 18 and overa |
2014 | |||
NRT products / e-cigarettes used in past 3 months |
Age | Total | ||
---|---|---|---|---|
18-44 | 45-64 | 65+ | ||
% | % | % | % | |
Men | ||||
Nicotine gum | 16 | 20 | 11 | 17 |
Nicotine patches on skin | 31 | 37 | 34 | 34 |
Nasal spray / nicotine inhaler | 9 | 7 | 8 | 8 |
Lozenge / microtab | 4 | 9 | 6 | 7 |
Champix / Varenicline | 6 | 8 | 3 | 7 |
Zyban / Bupropion | - | 4 | - | 2 |
E-cigarette | 38 | 30 | 14 | 32 |
Other | 5 | 1 | 2 | 3 |
Any product used | 61 | 64 | 41 | 60 |
No products used | 39 | 36 | 59 | 40 |
Women | ||||
Nicotine gum | 20 | 13 | 17 | 17 |
Nicotine patches on skin | 40 | 38 | 37 | 39 |
Nasal spray / nicotine inhaler | 9 | 10 | 10 | 10 |
Lozenge / microtab | 5 | 8 | 8 | 7 |
Champix / Varenicline | 7 | 7 | 7 | 7 |
Zyban / Bupropion | 2 | 3 | 4 | 3 |
E-cigarette | 33 | 37 | 17 | 33 |
Other | 3 | 1 | 0 | 2 |
Any product used | 66 | 72 | 58 | 67 |
No products used | 34 | 28 | 42 | 33 |
All adults | ||||
Nicotine gum | 18 | 17 | 14 | 17 |
Nicotine patches on skin | 36 | 38 | 35 | 36 |
Nasal spray / nicotine inhaler | 9 | 8 | 9 | 9 |
Lozenge / microtab | 5 | 9 | 7 | 7 |
Champix / Varenicline | 6 | 8 | 5 | 7 |
Zyban / Bupropion | 1 | 3 | 2 | 2 |
E-cigarette | 35 | 34 | 16 | 32 |
Other | 4 | 1 | 1 | 2 |
Any product used | 64 | 68 | 50 | 64 |
No products used | 36 | 32 | 50 | 36 |
Bases (weighted): | ||||
Men | 185 | 191 | 50 | 425 |
Women | 231 | 189 | 60 | 480 |
All adults | 416 | 380 | 109 | 905 |
Bases (unweighted): | ||||
Men | 151 | 173 | 62 | 386 |
Women | 223 | 184 | 80 | 487 |
All adults | 374 | 357 | 142 | 873 |
a These questions were not asked in the self-completion for adults aged 16-17
Contact
Email: Julie Landsberg
There is a problem
Thanks for your feedback